MedTech Dive January 2, 2025
Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.
Medtech dealmaking picked up in 2024 after a post-pandemic slump, with deals ranging from multibillion-dollar takeovers to smaller tuck-in acquisitions and the shedding of business groups.
In a recent investor note, BTIG analysts wrote that 38 acquisitions had closed by Dec. 12, compared to 22 across all of 2023. The number of takeovers was still below the 48 completed in 2021, but 2024 was the second busiest year for deals since 2011, according to the analysts.
Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical, and companies continued to expand their portfolios. Artificial intelligence was a focus...
Today's Sponsors
Today's Sponsor